Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
3
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
eli lilly
fda
lasmiditan
migraine
teva pharmaceutical
triptans
abalos therapeutics
acetonid
achillion pharmaceuticals
aglios therapeutics
alder biopharmaceutical
alexion pharmaceuticals
What
drugs
3
×
new
3
×
drug
approval
arguments
bails
big
bio
brand
bridgebio
capital
car
cholesterol
class
commercialized
companies
competitors
decades
develop
emerges
expensive
faces
fda
financial
firm
foe
grab
headlines
healthcare
hint
ichnos
inhibitors
invest
known
life
lowering
make
meeting
migraine
millions
Language
unset
Current search:
xconomy.com
×
drugs
×
" detroit blog main "
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
